NCT01433120View on ClinicalTrials.gov

Targeting the Gut Microbiome to Investigate the Pathways of Progression From Obesity to Metabolic Diseases in an At-risk Population.

NACompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

August 31, 2013

Conditions
ObesityInsulin Resistance
Interventions
DIETARY_SUPPLEMENT

Lactobacillus paracasei ssp paracasei F19

10\^10 CFU of Lactobacillus paracasei F19 (dissolved in a glass of water once per day)

DIETARY_SUPPLEMENT

Flax seed fibres

10 grams of flax seed fibres per day (baked into two breakfast buns)

DIETARY_SUPPLEMENT

Maltodextrin (Placebo)

Maltodextrin is dissolved in a glas of water once per day

Trial Locations (1)

1958

Department of Human Nutrition, Faculty of Life Sciences, University of Copenhagen, Frederiksberg C

All Listed Sponsors
collaborator

Lundbeck Foundation

OTHER

collaborator

Arla Foods

INDUSTRY

lead

University of Copenhagen

OTHER

NCT01433120 - Targeting the Gut Microbiome to Investigate the Pathways of Progression From Obesity to Metabolic Diseases in an At-risk Population. | Biotech Hunter | Biotech Hunter